Drug Trial Radar · NCT00049751
Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Aug 15, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,000
Actual
Start
Sep 2002
Primary completion
Not stated
Sponsor
- Lead sponsor
- AbbottIndustry
- Sponsor type
- Industry
- First posted
- Nov 14, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate safety by collecting serious adverse events in subjects with moderately to severely active rheumatoid arthritis who are unable to obtain etanercept and who have failed one or more prior disease-modifying antirheumatic drugs (DMARDs).
Conditions
- Rheumatoid Arthritis
Interventions
AdalimumabDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in disease activity score at visit week 12 as compared to baseline
Locations
54 sites in 1 country. Site status is shown where the registry gives one.
Thomas McGee, MD
Mobile, Alabama
Desert Valley Medical
Apple Valley, California
Kenneth Hsu, MD, Inc.
Bakersfield, California
Rheumatology Clinic
Los Angeles, California
Michael Harrington, MD
Napa, California
Midori Jane Nishio, MD
Walnut Creek, California
Naveen Raja, MD
Whittier, California
Mountain Rheumatology
Denver, Colorado
Division of Rheumatic Diseases/University of CT Health Center
Farmington, Connecticut
New Haven Medical Group, PC
New Haven, Connecticut
Norman Gaylis, MD
Aventura, Florida
Mike Schweitz, MD
West Palm Beach, Florida
Maurice McCarthy, MD
Winter Haven, Florida
Intermountain Orthopedics
Boise, Idaho
Institute of Arthritis Research
Idaho Falls, Idaho
Loyola University Medical Center
Maywood, Illinois
West Suburban Health Care
Oak Park, Illinois
OSF Medical Group -Rheumatology
Peoria, Illinois
Rockford Clinic, Clinical Research Department
Rockton, Illinois
Pain Therapy Center
Schaumburg, Illinois
Baton Rouge Clinic
Baton Rouge, Louisiana
Thomas Pressly, MD
Shreveport, Louisiana
Rheumatology Associates
Portland, Maine
Northampton Internal Medicine Association
Northampton, Massachusetts
Fallon Clinic Research
West Boylston, Massachusetts
John Howland, MD
Bay City, Michigan
Freeman Health Systems
Joplin, Missouri
Peggy Schlesinger, MD
Missoula, Montana
NJ Associates in Medicine
Fair Lawn, New Jersey
Internal Medicine and Rheumatic Diseases
Millburn, New Jersey
Placido Morano, MD
Brooklyn, New York
NYU Hospital for Joint Disease
New York, New York
Alan Kaell, MD
Port Jefferson Station, New York
Carolina Bone and Joint, PA
Monroe, North Carolina
Gordon Senter, MD Rheumatology, PA
Salisbury, North Carolina
MedCenter One Health Systems
Bismarck, North Dakota
University Hospital of Cleveland
Beachwood, Ohio
Arthritis Clinic
Canton, Ohio
STAT Research, Inc.
Dayton, Ohio
Arthritis and Osteoporosis Clinic, LLC
Bend, Oregon
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.